Drugs / PDI-320 Monad #1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01828177 | Jun 2013 → Jun 2014 | rosacea | PreCision Dermatology, Inc. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PDI-320 Monad #1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01828177 ↗ |